ARCHIVES

FDA Advisors Debate Ban, Black Box And Status Quo of Power Morcellators

This article is from The Cancer Letter archive.

Vol. 40 No. 30 | July 25, 2014

Download PDF Visit The Full Archive

Related Articles

Gates, Bloomberg Fund Project To Reduce Tobacco Use.

July 25, 2008

Avastin-Zybrestat Combination Increases Progression-Free Survival in Phase II Trial

March 28, 2014

Cancer Control RFA Announcements

March 9, 1979

Broder On FDA: Don’t Blame Them For Doing Their Jobs (They Have To Work At Parklawn)

September 27, 1991

Drugs and Targets: FDA extends Lymphoseek label to include mapping in solid tumors

October 31, 2014

NIH Cancer Nurse Turnover Down to 10%

July 24, 1987